Protease Nexin-1 - a serpin with a possible proinvasive role in cancer

Matrix Proteases in Health and Disease

Volumn , Issue , 2012, Pages 251-281

  Kousted, Tina M ^a   Jensen, Jan K ^a   Gao, Shan ^a   Andreasen, Peter A ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

animals; biochemistry; cancer; cell culture; expression; Glia derived nexin (GDN); metabolism; metastasis; plasminogen; prognosis; serine protease inhibitors; serpinE2

Indexed keywords

EID: 84885730237     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527649327.ch10     Document Type: Chapter

References (175)

1. Irving, J.A., Pike, R.N., Lesk, A.M., and Whisstock, J.C. (2000) Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function. Genome Res., 10, 1845-1864.
2. Huntington, J.A. (2006) Shape-shifting serpins-advantages of a mobile mechanism. Trends Biochem. Sci., 31, 427-435.
3. Silverman, G.A., Bird, P.I., Carrell, R.W., Church, F.C., Coughlin, P.B., Gettins, P.G., Irving, J.A., Lomas, D.A., Luke, C.J., Moyer, R.W., Pemberton, P.A., Remold-O'Donnell, E., Salvesen, G.S., Travis, J., and Whisstock, J.C. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem., 276, 33293-33296.
4. Gettins, P.G. (2002) Serpin structure, mechanism, and function. Chem. Rev., 102, 4751-4804.
5. Silverman, G.A., Whisstock, J.C., Bottomley, S.P., Huntington, J.A., Kaiserman, D., Luke, C.J., Pak, S.C., Reichhart, J.M., and Bird, P.I. (2010) Serpins flex their muscle: I. Putting the clamps on proteolysis in diverse biological systems. J. Biol. Chem., 285, 24299-24305.
6. Ragg, H. (2007) The role of serpins in the surveillance of the secretory pathway. Cell. Mol. Life Sci., 64, 2763-2770.
7. Zhang, M., Martin, K.J., Sheng, S., and Sager, R. (1998) Expression genetics: a different approach to cancer diagnosis and prognosis. Trends Biotechnol., 16, 66-71.
8. Xiao, G., Liu, Y.E., Gentz, R., Sang, Q.A., Ni, J., Goldberg, I.D., and Shi, Y.E. (1999) Suppression of breast cancer growth and metastasis by a serpin myoepithelium-derived serine proteinase inhibitor expressed in the mammary myoepithelial cells. Proc. Natl. Acad. Sci. U.S.A., 96, 3700-3705.
9. Andreasen, P.A., Kjoller, L., Christensen, L., and Duffy, M.J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer, 72, 1-22.
10. Andreasen, P.A., Egelund, R., and Petersen, H.H. (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell. Mol. Life Sci., 57, 25-40.
11. Janicke, F., Prechtl, A., Thomssen, C., Harbeck, N., Meisner, C., Untch, M., Sweep, C.G., Selbmann, H.K., Graeff, H., and Schmitt, M. (2001) Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. J. Natl. Cancer Inst., 93, 913-920.
12. Harbeck, N., Kates, R.E., and Schmitt, M. (2002) Clinical relevance of invasion factors urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 for individualized therapy decisions in primary breast cancer is greatest when used in combination. J. Clin. Oncol., 20, 1000-1007.
13. Look, M.P., van Putten, W.L., Duffy, M.J., Harbeck, N., Christensen, I.J., Thomssen, C., Kates, R., Spyratos, F., Ferno, M., Eppenberger-Castori, S., Sweep, C.G., Ulm, K., Peyrat, J.P., Martin, P.M., Magdelenat, H., Brunner, N., Duggan, C., Lisboa, B.W., Bendahl, P.O., Quillien, V., Daver, A., Ricolleau, G., Meijer-van Gelder, M.E., Manders, P., Fiets, W.E., Blankenstein, M.A., Broet, P., Romain, S., Daxenbichler, G., Windbichler, G., Cufer, T., Borstnar, S., Kueng, W., Beex, L.V., Klijn, J.G., O'Higgins, N., Eppenberger, U., Janicke, F., Schmitt, M., and Foekens, J.A. (2002) Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. J. Natl. Cancer Inst., 94, 116-128.
14. Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M.R., Hayes, D.F., and Bast, R.C. Jr., American Society of Clinical Oncology (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol., 25, 5287-5312.
15. Durand, M.K., Bodker, J.S., Christensen, A., Dupont, D.M., Hansen, M., Jensen, J.K., Kjelgaard, S., Mathiasen, L., Pedersen, K.E., Skeldal, S., Wind, T., and Andreasen, P.A. (2004) Plasminogen activator inhibitor-I and tumour growth, invasion, and metastasis. Thromb. Haemostasis, 91, 438-449.
16. Andreasen, P.A. (2007) PAI-1 - a potential therapeutic target in cancer. Curr. Drug Targets, 8, 1030-1041.
17. Dupont, D.M., Madsen, J.B., Kristensen, T., Bodker, J.S., Blouse, G.E., Wind, T., and Andreasen, P.A. (2009) Biochemical properties of plasminogen activator inhibitor-1. Front. Biosci., 14, 1337-1361.
18. Monard, D., Solomon, F., Rentsch, M., and Gysin, R. (1973) Glia-induced morphological differentiation in neuroblastoma cells. Proc. Natl. Acad. Sci. U.S.A., 70, 1894-1897.
19. Schurch-Rathgeb, Y.M.D. (1978) Brain development influences the appearance of glial factor-like activity in rat brain primary cultures. Nature, 273, 308-309.
20. Baker, J.B., Low, D.A., Simmer, R.L., and Cunningham, D.D. (1980) Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell, 21, 37-45.
21. Low, D.A., Baker, J.B., Koonce, W.C., and Cunningham, D.D. (1981) Released protease-nexin regulates cellular binding, internalization, and degradation of serine proteases. Proc. Natl. Acad. Sci. U.S.A., 78, 2340-2344.
22. Monard, D., Niday, E., Limat, A., and Solomon, F. (1983) Inhibition of protease activity can lead to neurite extension in neuroblastoma cells. Prog. Brain Res., 58, 359-364.
23. Scott, R.W. and Baker, J.B. (1983) Purification of human protease nexin. J. Biol. Chem., 258, 10439-10444.
24. Guenther, J., Nick, H., and Monard, D. (1985) A glia-derived neurite-promoting factor with protease inhibitory activity. EMBO J., 4, 1963-1966.
25. Scott, R.W., Bergman, B.L., Bajpai, A., Hersh, R.T., Rodriguez, H., Jones, B.N., Barreda, C., Watts, S., and Baker, J.B. (1985) Protease nexin. Properties and a modified purification procedure. J. Biol. Chem., 260, 7029-7034.
26. Gloor, S., Odink, K., Guenther, J., Nick, H., and Monard, D. (1986) A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell, 47, 687-693.
27. Sommer, J., Gloor, S.M., Rovelli, G.F., Hofsteenge, J., Nick, H., Meier, R., and Monard, D. (1987) cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily. Biochemistry, 26, 6407-6410.
28. Wagner, S.L., Van Nostrand, W.E., Lau, A.L., and Cunningham, D.D. (1988) Monoclonal antibodies to protease nexin 1 that differentially block its inhibition of target proteases. Biochemistry, 27, 2173-2176.
29. Guttridge, D.C. and Cunningham, D.D. (1996) Characterization of the human protease nexin-1 promoter and its regulation by Sp1 through a G/C-rich activation domain. J. Neurochem., 67, 498-507.
30. Murer, V., Spetz, J.F., Hengst, U., Altrogge, L.M., de Agostini, A., and Monard, D. (2001) Male fertility defects in mice lacking the serine protease inhibitor protease nexin-1. Proc. Natl. Acad. Sci. U.S.A., 98, 3029-3033.
31. Carter, R.E., Cerosaletti, K.M., Burkin, D.J., Fournier, R.E., Jones, C., Greenberg, B.D., Citron, B.A., and Festoff, B.W. (1995) The gene for the serpin thrombin inhibitor (PI7), protease nexin I, is located on human chromosome 2q33-q35 and on syntenic regions in the mouse and sheep genomes. Genomics, 27, 196-199.
32. Klinger, K.W., Winqvist, R., Riccio, A., Andreasen, P.A., Sartorio, R., Nielsen, L.S., Stuart, N., Stanislovitis, P., Watkins, P., Douglas, R. et al. (1987) Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis. Proc. Natl. Acad. Sci. U.S.A., 84, 8548-8552.
33. McGrogan, M., Kennedy, J., Li, M.P., Hsu, C., Scott, R.W., Simonsen, C.C., and Baker, J.B. (1988) Molecular cloning and expression of two forms of human protease nexin I. Biotechnology, 6, 172-177.
34. Jensen, J.K., Thompson, L.C., Bucci, J.C., Nissen, P., Gettins, P.G., Peterson, C.B., Andreasen, P.A., and Morth, J.P. (2011) Crystal structure of plasminogen activator inhibitor-1 in an active conformation with normal thermodynamic stability. J. Biol. Chem., 286, 29709-29717.
35. Evans, D.L., McGrogan, M., Scott, R.W., and Carrell, R.W. (1991) Protease specificity and heparin binding and activation of recombinant protease nexin I. J. Biol. Chem., 266, 22307-22312.
36. Rovelli, G., Stone, S.R., Guidolin, A., Sommer, J., and Monard, D. (1992) Characterization of the heparin-binding site of glia-derived nexin/protease nexin-1. Biochemistry, 31, 3542-3549.
37. Stone, S.R., Brown-Luedi, M.L., Rovelli, G., Guidolin, A., McGlynn, E., and Monard, D. (1994) Localization of the heparin-binding site of glia-derived nexin/protease nexin-1 by site-directed mutagenesis. Biochemistry, 33, 7731-7735.
38. Knauer, M.F., Hawley, S.B., and Knauer, D.J. (1997) Identification of a binding site in protease nexin I (PN1) required for the receptor mediated internalization of PN1-thrombin complexes. J. Biol. Chem., 272, 12261-12264.
39. Knauer, M.F., Crisp, R.J., Kridel, S.J., and Knauer, D.J. (1999) Analysis of a structural determinant in thrombin-protease nexin 1 complexes that mediates clearance by the low density lipoprotein receptor-related protein. J. Biol. Chem., 274, 275-281.
40. Lin, Z., Jiang, L., Yuan, C., Jensen, J.K., Zhang, X., Luo, Z., Furie, B.C., Furie, B., Andreasen, P.A., and Huang, M. (2011) Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1. J. Biol. Chem., 286, 7027-32.
41. Dementiev, A., Dobo, J., and Gettins, P.G. (2006) Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase. J. Biol. Chem., 281, 3452-3457.
42. Jensen, J.K. and Gettins, P.G. (2008) High-resolution structure of the stable plasminogen activator inhibitor type-1 variant 14-1B in its proteinase-cleaved form: a new tool for detailed interaction studies and modeling. Protein Sci., 17, 1844-1849.
43. Wallace, A., Rovelli, G., Hofsteenge, J., and Stone, S.R. (1989) Effect of heparin on the glia-derived-nexin-thrombin interaction. Biochem. J., 257, 191-196.
44. Herndon, M.E., Stipp, C.S., and Lander, A.D. (1999) Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: assessment of selectivity, heterogeneity and the participation of core proteins in binding. Glycobiology, 9, 143-155.
45. Richard, B., Pichon, S., Arocas, V., Venisse, L., Berrou, E., Bryckaert, M., Jandrot-Perrus, M., and Bouton, M.C. (2006) The serpin protease nexin-1 regulates vascular smooth muscle cell adhesion, spreading, migration and response to thrombin. J. Thromb. Haemostasis, 4, 322-328.
46. Johnson, D.J., Langdown, J., and Huntington, J.A. (2010) Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex. Proc. Natl. Acad. Sci. U.S.A., 107, 645-650.
47. Baglin, T.P., Carrell, R.W., Church, F.C., Esmon, C.T., and Huntington, J.A. (2002) Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism. Proc. Natl. Acad. Sci. U.S.A., 99, 11079-11084.
48. Ehrlich, H.J., Gebbink, R.K., Keijer, J., and Pannekoek, H. (1992) Elucidation of structural requirements on plasminogen activator inhibitor 1 for binding to heparin. J. Biol. Chem., 267, 11606-11611.
49. Rovelli, G., Stone, S.R., Preissner, K.T., and Monard, D. (1990) Specific interaction of vitronectin with the cell-secreted protease inhibitor glia-derived nexin and its thrombin complex. Eur. J. Biochem., 192, 797-803.
50. Ye, S. and Goldsmith, E.J. (2001) Serpins and other covalent protease inhibitors. Curr. Opin. Struct. Biol., 11, 740-745.
51. Wind, T., Hansen, M., Jensen, J.K., and Andreasen, P.A. (2002) The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment. Biol. Chem., 383, 21-36.
52. Ye, S., Cech, A.L., Belmares, R., Bergstrom, R.C., Tong, Y., Corey, D.R., Kanost, M.R., and Goldsmith, E.J. (2001) The structure of a Michaelis serpin-protease complex. Nat. Struct. Biol., 8, 979-983.
53. Li, W., Johnson, D.J., Esmon, C.T., and Huntington, J.A. (2004) Structure of the antithrombin-thrombin-heparin ternary complex reveals the antithrombotic mechanism of heparin. Nat. Struct. Mol. Biol., 11, 857-862.
54. Li, W., Adams, T.E., Nangalia, J., Esmon, C.T., and Huntington, J.A. (2008) Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-A structure of the heparin-bridged complex. Proc. Natl. Acad. Sci. U.S.A., 105, 4661-4666.
55. Johnson, D.J., Li, W., Adams, T.E., and Huntington, J.A. (2006) Antithrombin-S195A factor Xa-heparin structure reveals the allosteric mechanism of antithrombin activation. EMBO J., 25, 2029-2037.
56. Huntington, J.A., Read, R.J., and Carrell, R.W. (2000) Structure of a serpin-protease complex shows inhibition by deformation. Nature, 407, 923-926.
57. Chen, L.M., Skinner, M.L., Kauffman, S.W., Chao, J., Chao, L., Thaler, C.D., and Chai, K.X. (2001) Prostasin is a glycosylphosphatidylinositol-anchored active serine protease. J. Biol. Chem., 276, 21434-21442.
58. Chen, L.M., Zhang, X., and Chai, K.X. (2004) Regulation of prostasin expression and function in the prostate. Prostate, 59, 1-12.
59. Myerburg, M.M., McKenna, E.E., Luke, C.J., Frizzell, R.A., Kleyman, T.R., and Pilewski, J.M. (2008) Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol., 294, L932-L941.
60. Muhl, L., Nykjaer, A., Wygrecka, M., Monard, D., Preissner, K.T., and Kanse, S.M. (2007) Inhibition of PDGF-BB by factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP. Biochem. J., 404, 191-196.
61. Djie, M.Z., Stone, S.R., and Le Bonniec, B.F. (1997) Intrinsic specificity of the reactive site loop of alpha1-antitrypsin, alpha1-antichymotrypsin, antithrombin III, and protease nexin I. J. Biol. Chem., 272, 16268-16273.
62. Crisp, R.J., Knauer, M.F., and Knauer, D.J. (2002) Protease nexin 1 is a potent urinary plasminogen activator inhibitor in the presence of collagen type IV. J. Biol. Chem., 277, 47285-47291.
63. Eaton, D.L., Scott, R.W., and Baker, J.B. (1984) Purification of human fibroblast urokinase proenzyme and analysis of its regulation by proteases and protease nexin. J. Biol. Chem., 259, 6241-6247.
64. Knauer, D.J., Majumdar, D., Fong, P.C., and Knauer, M.F. (2000) SERPIN regulation of factor XIa. The novel observation that protease nexin 1 in the presence of heparin is a more potent inhibitor of factor XIa than C1 inhibitor. J. Biol. Chem., 275, 37340-37346.
65. Van Nostrand, W.E., Wagner, S.L., and Cunningham, D.D. (1988) Purification of a form of protease nexin 1 that binds heparin with a low affinity. Biochemistry, 27, 2176-2181.
66. Torri, G., Casu, B., Gatti, G., Petitou, M., Choay, J., Jacquinet, J.C., and Sinay, P. (1985) Mono- and bidimensional 500MHz 1H-NMR spectra of a synthetic pentasaccharide corresponding to the binding sequence of heparin to antithrombin-III: evidence for conformational peculiarity of the sulfated iduronate residue. Biochem. Biophys. Res. Commun., 128, 134-140.
67. Choay, J. (1989) Chemically synthesized heparin-derived oligosaccharides. Ann. N.Y. Acad. Sci., 556, 61-74.
68. Huntington, J.A. (2003) Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J. Thromb. Haemostasis, 1, 1535-1549.
69. Lindahl, U., Backstrom, G., Thunberg, L., and Leder, I.G. (1980) Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc. Natl. Acad. Sci. U.S.A., 77, 6551-6555.
70. Olson, S.T., Bjork, I., Sheffer, R., Craig, P.A., Shore, J.D., and Choay, J. (1992) Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J. Biol. Chem., 267, 12528-12538.
71. Dementiev, A., Petitou, M., Herbert, J.M., and Gettins, P.G. (2004) The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity. Nat. Struct. Mol. Biol., 11, 863-867.
72. Gliemann, J., Nykjaer, A., Petersen, C.M., Jorgensen, K.E., Nielsen, M., Andreasen, P.A., Christensen, E.I., Lookene, A., Olivecrona, G., and Moestrup, S.K. (1994) The multiligand alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein (alpha 2MR/LRP). Binding and endocytosis of fluid phase and membrane-associated ligands. Ann. N.Y. Acad. Sci., 737, 20-38.
73. Nykjaer, A. and Willnow, T.E. (2002) The low-density lipoprotein receptor gene family: a cellular Swiss army knife? Trends Cell Biol., 12, 273-280.
74. Lillis, A.P., Mikhailenko, I., and Strickland, D.K. (2005) Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability. J. Thromb. Haemostasis, 3, 1884-1893.
75. Strickland, D.K. and Medved, L. (2006) Low-density lipoprotein receptor-related protein (LRP)-mediated clearance of activated blood coagulation co-factors and proteases: clearance mechanism or regulation? J. Thromb. Haemostasis, 4, 1484-1486.
76. Kristensen, T., Moestrup, S.K., Gliemann, J., Bendtsen, L., Sand, O., and Sottrup-Jensen, L. (1990) Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is the alpha 2-macroglobulin receptor. FEBS Lett., 276, 151-155.
77. Strickland, D.K., Ashcom, J.D., Williams, S., Burgess, W.H., Migliorini, M., and Argraves, W.S. (1990) Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J. Biol. Chem., 265, 17401-17404.
78. Herz, J., Hamann, U., Rogne, S., Myklebost, O., Gausepohl, H., and Stanley, K.K. (1988) Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. EMBO J., 7, 4119-4127.
79. Orth, K., Madison, E.L., Gething, M.J., Sambrook, J.F., and Herz, J. (1992) Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Proc. Natl. Acad. Sci. U.S.A., 89, 7422-7426.
80. Nykjaer, A., Petersen, C.M., Moller, B., Jensen, P.H., Moestrup, S.K., Holtet, T.L., Etzerodt, M., Thogersen, H.C., Munch, M., Andreasen, P.A. et al. (1992) Purified alpha 2-macroglobulin receptor/LDL receptor-related protein binds urokinase.plasminogen activator inhibitor type-1 complex. Evidence that the alpha 2-macroglobulin receptor mediates cellular degradation of urokinase receptor-bound complexes. J. Biol. Chem., 267, 14543-14546.
81. Strickland, D.K. and Ranganathan, S. (2003) Diverse role of LDL receptor-related protein in the clearance of proteases and in signaling. J. Thromb. Haemostasis, 1, 1663-1670.
82. Jensen, J.K., Dolmer, K., Schar, C., and Gettins, P.G. (2009) Receptor-associated protein (RAP) has two high-affinity binding sites for the low-density lipoprotein receptor-related protein (LRP): consequences for the chaperone functions of RAP. Biochem. J., 421, 273-282.
83. Jensen, G.A., Andersen, O.M., Bonvin, A.M., Bjerrum-Bohr, I., Etzerodt, M., Thogersen, H.C., O'Shea, C., Poulsen, F.M., and Kragelund, B.B. (2006) Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif. J. Mol. Biol., 362, 700-716.
84. Howard, E.W. and Knauer, D.J. (1987) Characterization of the receptor for protease nexin-I:protease complexes on human fibroblasts. J. Cell. Physiol., 131, 276-283.
85. Conese, M., Olson, D., and Blasi, F. (1994) Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha 2-macroglobulin receptor. J. Biol. Chem., 269, 17886-17892.
86. Kasza, A., Petersen, H.H., Heegaard, C.W., Oka, K., Christensen, A., Dubin, A., Chan, L., and Andreasen, P.A. (1997) Specificity of serine proteinase/ serpin complex binding to very-low-density lipoprotein receptor and alpha2-macroglobulin receptor/low-density-lipoproteinreceptor- related protein. Eur. J. Biochem., 248, 270-281.
87. Rettenberger, P.M., Oka, K., Ellgaard, L., Petersen, H.H., Christensen, A., Martensen, P.M., Monard, D., Etzerodt, M., Chan, L., and Andreasen, P.A. (1999) Ligand binding properties of the very low density lipoprotein receptor. Absence of the third complement-type repeat encoded by exon 4 is associated with reduced binding of Mr 40,000 receptor-associated protein. J. Biol. Chem., 274, 8973-8980.
88. Knauer, M.F., Kridel, S.J., Hawley, S.B., and Knauer, D.J. (1997) The efficient catabolism of thrombin-protease nexin 1 complexes is a synergistic mechanism that requires both the LDL receptor-related protein and cell surface heparins. J. Biol. Chem., 272, 29039-29045.
89. Mentz, S., de Lacalle, S., Baerga-Ortiz, A., Knauer, M.F., Knauer, D.J., and Komives, E.A. (1999) Mechanism of thrombin clearance by human astrocytoma cells. J. Neurochem., 72, 980-987.
90. Crisp, R.J., Knauer, D.J., and Knauer, M.F. (2000) Roles of the heparin and low density lipid receptor-related protein-binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or internalization. J. Biol. Chem., 275, 19628-19637.
91. Jensen, J.K., Dolmer, K., and Gettins, P.G. (2009) Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1. J. Biol. Chem., 284, 17989-17997.
92. Skeldal, S., Larsen, J.V., Pedersen, K.E., Petersen, H.H., Egelund, R., Christensen, A., Jensen, J.K., Gliemann, J., and Andreasen, P.A. (2006) Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis. FEBS J., 273, 5143-5159.
93. Verdaguer, N., Fita, I., Reithmayer, M., Moser, R., and Blaas, D. (2004) X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein. Nat. Struct. Mol. Biol., 11, 429-434.
94. Fisher, C., Beglova, N., and Blacklow, S.C. (2006) Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol. Cell, 22, 277-283.
95. Farrell, D.H. and Cunningham, D.D. (1986) Human fibroblasts accelerate the inhibition of thrombin by protease nexin. Proc. Natl. Acad. Sci. U.S.A., 83, 6858-6862.
96. Farrell, D.H. and Cunningham, D.D. (1987) Glycosaminoglycans on fibroblasts accelerate thrombin inhibition by protease nexin-1. Biochem. J., 245, 543-550.
97. Conese, M., Nykjaer, A., Petersen, C.M., Cremona, O., Pardi, R., Andreasen, P.A., Gliemann, J., Christensen, E.I., and Blasi, F. (1995) Alpha-2 Macroglobulin receptor/Ldl receptor-related protein(Lrp)-dependent internalization of the urokinase receptor. J. Cell Biol., 131, 1609-1622.
98. Li, X., Herz, J., and Monard, D. (2006) Activation of ERK signaling upon alternative protease nexin-1 internalization mediated by syndecan-1. J. Cell. Biochem., 99, 936-951.
99. Fayard, B., Bianchi, F., Dey, J., Moreno, E., Djaffer, S., Hynes, N.E., and Monard, D. (2009) The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Res., 69, 5690-5698.
100. Vaillant, C., Michos, O., Orolicki, S., Brellier, F., Taieb, S., Moreno, E., Te, H., Zeller, R., and Monard, D. (2007) Protease nexin 1 and its receptor LRP modulate SHH signalling during cerebellar development. Development, 134, 1745-1754.
101. Bergman, B.L., Scott, R.W., Bajpai, A., Watts, S., and Baker, J.B. (1986) Inhibition of tumor-cell-mediated extracellular matrix destruction by a fibroblast proteinase inhibitor, protease nexin I. Proc. Natl. Acad. Sci. U.S.A., 83, 996-1000.
102. Rossignol, P., Bouton, M.C., Jandrot-Perrus, M., Bryckaert, M., Jacob, M.P., Bezeaud, A., Guillin, M.C., Michel, J.B., and Meilhac, O. (2004) A paradoxical pro-apoptotic effect of thrombin on smooth muscle cells. Exp. Cell Res., 299, 279-285.
103. Rossignol, P., Ho-Tin-Noe, B., Vranckx, R., Bouton, M.C., Meilhac, O., Lijnen, H.R., Guillin, M.C., Michel, J.B., and Angles-Cano, E. (2004) Protease nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells. J. Biol. Chem., 279, 10346-10356.
104. Lindner, J., Guenther, J., Nick, H., Zinser, G., Antonicek, H., Schachner, M., and Monard, D. (1986) Modulation of granule cell migration by a glia-derived protein. Proc. Natl. Acad. Sci. U.S.A., 83, 4568-4571.
105. Drapkin, P.T., Monard, D., and Silverman, A.J. (2002) The role of serine proteases and serine protease inhibitors in the migration of gonadotropin-releasing hormone neurons. BMC Dev. Biol., 2, 1.
106. Kanse, S.M., Chavakis, T., Al-Fakhri, N., Hersemeyer, K., Monard, D., and Preissner, K.T. (2004) Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1. J. Cell Sci., 117, 477-485.
107. Czekay, R.P. and Loskutoff, D.J. (2009) Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism. J. Cell. Physiol., 220, 655-663.
108. Leroy-Viard, K., Jandrot-Perrus, M., Tobelem, G., and Guillin, M.C. (1989) Covalent binding of human thrombin to a human endothelial cell-associated protein. Exp. Cell Res., 181, 1-10.
109. Mbebi, C., Hantai, D., Jandrot-Perrus, M., Doyennette, M.A., and Verdiere-Sahuque, M. (1999) Protease nexin I expression is up-regulated in human skeletal muscle by injury-related factors. J. Cell. Physiol., 179, 305-314.
110. Bouton, M.C., Richard, B., Rossignol, P., Philippe, M., Guillin, M.C., Michel, J.B., and Jandrot-Perrus, M. (2003) The serpin protease-nexin 1 is present in rat aortic smooth muscle cells and is upregulated in L-NAME hypertensive rats. Arterioscler. Thromb. Vasc. Biol., 23, 142-147.
111. Wakida, N., Kitamura, K., Tuyen, D.G., Maekawa, A., Miyoshi, T., Adachi, M., Shiraishi, N., Ko, T., Ha, V., Nonoguchi, H., and Tomita, K. (2006) Inhibition of prostasin-induced ENaC activities by PN-1 and regulation of PN-1 expression by TGF-beta1 and aldosterone. Kidney Int., 70, 1432-1438.
112. Gao, S. and Andreasen, P.A. (2011) DNA methylation profiles of protease nexin 1 (SERPINE2) gene in human cell lines. Chin. J. Cancer Res., 23, 92-98.
113. Vaughan, P.J. and Cunningham, D.D. (1993) Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors. J. Biol. Chem., 268, 3720-3727.
114. Guttridge, D.C., Lau, A.L., and Cunningham, D.D. (1993) Protease nexin-1, a thrombin inhibitor, is regulated by interleukin-1 and dexamethasone in normal human fibroblasts. J. Biol. Chem., 268, 18966-18974.
115. Hultman, K., Blomstrand, F., Nilsson, M., Wilhelmsson, U., Malmgren, K., Pekny, M., Kousted, T., Jern, C., and Tjarnlund-Wolf, A. (2010) Expression of plasminogen activator inhibitor-1 and protease nexin-1 in human astrocytes: Response to injury-related factors. J. Neurosci. Res., 88, 2441-2449.
116. Kasza, A., Kowanetz, M., Poslednik, K., Witek, B., Kordula, T., and Koj, A. (2001) Epidermal growth factor and pro-inflammatory cytokines regulate the expression of components of plasminogen activation system in U373-MG astrocytoma cells. Cytokine, 16, 187-190.
117. Festoff, B.W., Nelson, P.G., and Brenneman, D.E. (1996) Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting neurotrophic serpin, protease nexin I. J. Neurobiol., 30, 255-266.
118. Koshimizu, H., Kim, T., Cawley, N.X., and Loh, Y.P. (2010) Reprint of: Chromogranin A: a new proposal for trafficking, processing and induction of granule biogenesis. Regul. Pept., 165, 95-101.
119. Cao, M., Buratini, J. Jr., Lussier, J.G., Carriere, P.D., and Price, C.A. (2006) Expression of protease nexin-1 and plasminogen activators during follicular growth and the periovulatory period in cattle. Reproduction, 131, 125-137.
120. van der Horst, E.H., Chinn, L., Wang, M., Velilla, T., Tran, H., Madrona, Y., Lam, A., Ji, M., Hoey, T.C., and Sato, A.K. (2009) Discovery of fully human anti-MET monoclonal antibodies with antitumor activity against colon cancer tumor models in vivo. Neoplasia, 11, 355-364.
121. Bergeron, S., Lemieux, E., Durand, V., Cagnol, S., Carrier, J.C., Lussier, J.G., Boucher, M.J., and Rivard, N. (2010) The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis. Mol. Cancer, 9, 271.
122. Bleuel, A., Degasparo, M., Whitebread, S., Puttner, I., and Monard, D. (1995) Regulation of protease Nexin-1 expression in cultured Schwann-cells is mediated by Angiotensin-Ii receptors. J. Neurosci., 15, 750-761.
123. Kitamura, K. and Tomita, K. (2010) Regulation of renal sodium handling through the interaction between serine proteases and serine protease inhibitors. Clin. Exp. Nephrol., 14, 405-410.
124. Erno, H. and Monard, D. (1993) Molecular organization of the rat glia-derived nexin/protease nexin-1 promoter. Gene Expr., 3, 163-174.
125. Erno, H., Kury, P., Botteri, F.M., and Monard, D. (1996) A Krox binding site regulates protease nexin-1 promoter activity in embryonic heart, cartilage and parts of the nervous system. Mech. Dev., 60, 139-150.
126. Suzuki, S., Singhirunnusorn, P., Nakano, H., Doi, T., Saiki, I., and Sakurai, H. (2006) Identification of TNF-alpha-responsive NF-kappaB p65-binding element in the distal promoter of the mouse serine protease inhibitor SerpinE2. FEBS Lett., 580, 3257-3262.
127. Cortese, R., Hartmann, O., Berlin, K., and Eckhardt, F. (2008) Correlative gene expression and DNA methylation profiling in lung development nominate new biomarkers in lung cancer. Int. J. Biochem. Cell Biol., 40, 1494-1508.
128. Choi, B.H., Suzuki, M., Kim, T., Wagner, S.L., and Cunningham, D.D. (1990) Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Am. J. Pathol., 137, 741-747.
129. Mansuy, I.M., van der Putten, H., Schmid, P., Meins, M., Botteri, F.M., and Monard, D. (1993) Variable and multiple expression of Protease Nexin-1 during mouse organogenesis and nervous system development. Development, 119, 1119-1134.
130. Reinhard, E., Suidan, H.S., Pavlik, A., and Monard, D. (1994) Glia-derived nexin/protease nexin-1 is expressed by a subset of neurons in the rat brain. J. Neurosci. Res., 37, 256-270.
131. Xu, D., McKee, C.M., Cao, Y., Ding, Y., Kessler, B.M., and Muschel, R.J. (2010) Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res., 70, 6988-6998.
132. Vassalli, J.D., Huarte, J., Bosco, D., Sappino, A.P., Sappino, N., Velardi, A., Wohlwend, A., Erno, H., Monard, D., and Belin, D. (1993) Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle. EMBO J., 12, 1871-1878.
133. Hasan, S., Hosseini, G., Princivalle, M., Dong, J.C., Birsan, D., Cagide, C., and de Agostini, A.I. (2002) Coordinate expression of anticoagulant heparan sulfate proteoglycans and serine protease inhibitors in the rat ovary: a potent system of proteolysis control. Biol. Reprod., 66, 144-158.
134. Simpson, C.S., Johnston, H.M., and Morris, B.J. (1994) Neuronal expression of protease-nexin 1 mRNA in rat brain. Neurosci. Lett., 170, 286-290.
135. Gronke, R.S., Bergman, B.L., and Baker, J.B. (1987) Thrombin interaction with platelets. Influence of a platelet protease nexin. J. Biol. Chem., 262, 3030-3036.
136. Gronke, R.S., Knauer, D.J., Veeraraghavan, S., and Baker, J.B. (1989) A form of protease nexin I is expressed on the platelet surface during platelet activation. Blood, 73, 472-478.
137. Mansilla, S., Boulaftali, Y., Venisse, L., Arocas, V., Meilhac, O., Michel, J.B., Jandrot-Perrus, M., and Bouton, M.C. (2008) Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol., 28, 1844-1850.
138. Baker, J.B. and Gronke, R.S. (1986) Protease nexins and cellular regulation. Semin. Thromb. Hemost., 12, 216-220.
139. Lu, C.H., Lee, R.K., Hwu, Y.M., Chu, S.L., Chen, Y.J., Chang, W.C., Lin, S.P., and Li, S.H. (2010) SERPINE2, a serine protease inhibitor extensively expressed in adult male mouse reproductive tissues, may serve as a murine sperm decapacitation factor. Biol. Reprod., 84, 514-25.
140. Lwaleed, B.A., Greenfield, R., Stewart, A., Birch, B., and Cooper, A.J. (2004) Seminal clotting and fibrinolytic balance: a possible physiological role in the male reproductive system. Thromb. Haemost., 92, 752-766.
141. Price, C.A. (2008) Protease nexin-1 in reproductive tissues: a review. ARBS Annu. Rev. Biomed. Sci., 10, 75-83.
142. Rosenblatt, D.E., Cotman, C.W., Nieto-Sampedro, M., Rowe, J.W., and Knauer, D.J. (1987) Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I. Brain Res., 415, 40-48.
143. Reinhard, E., Meier, R., Halfter, W., Rovelli, G., and Monard, D. (1988) Detection of glia-derived nexin in the olfactory system of the rat. Neuron, 1, 387-394.
144. Kury, P., Schaeren-Wiemers, N., and Monard, D. (1997) Protease nexin-1 is expressed at the mouse met-/mesencephalic junction and FGF signaling regulates its promoter activity in primary met-/mesencephalic cells. Development, 124, 1251-1262.
145. Lino, M.M., Vaillant, C., Orolicki, S., Sticker, M., Kvajo, M., and Monard, D. (2010) Newly generated cells are increased in hippocampus of adult mice lacking a serine protease inhibitor. BMC Neurosci., 11, 70.
146. Luthi, A., van der Putten, H., Botteri, F.M., Mansuy, I.M., Meins, M., Frey, U., Sansig, G., Portet, C., Schmutz, M., Schroder, M., Nitsch, C., Laurent, J.P., and Monard, D. (1997) Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J. Neurosci., 17, 4688-4699.
147. Meins, M., Piosik, P., Schaeren-Wiemers, N., Franzoni, S., Troncoso, E., Kiss, J.Z., Brosamle, C., Schwab, M.E., Molnar, Z., and Monard, D. (2001) Progressive neuronal and motor dysfunction in mice overexpressing the serine protease inhibitor protease nexin-1 in postmitotic neurons. J. Neurosci., 21, 8830-8841.
148. Kvajo, M., Albrecht, H., Meins, M., Hengst, U., Troncoso, E., Lefort, S., Kiss, J.Z., Petersen, C.C., and Monard, D. (2004) Regulation of brain proteolytic activity is necessary for the in vivo function of NMDA receptors. J. Neurosci., 24, 9734-9743.
149. Monard, D., Suidan, H.S., and Nitsch, C. (1992) Relevance of the balance between glia-derived nexin and thrombin following lesion in the nervous system. Ann. N.Y. Acad. Sci., 674, 237-242.
150. Monard, D. (1993) Tinkering with certain blood components can engender distinct functions in the nervous system. Perspect Dev. Neurobiol., 1, 165-168.
151. Festoff, B.W., Smirnova, I.V., Ma, J., and Citron, B.A. (1996) Thrombin, its receptor and protease nexin I, its potent serpin, in the nervous system. Semin. Thromb. Hemost., 22, 267-271.
152. Turgeon, V.L. and Houenou, L.J. (1997) The role of thrombin-like (serine) proteases in the development, plasticity and pathology of the nervous system. Brain Res. Brain Res. Rev., 25, 85-95.
153. Wu, H., Zhao, R., Qi, J., Cong, Y., Wang, D., Liu, T., Gu, Y., Ban, X., and Huang, Q. (2008) The expression and the role of protease nexin-1 on brain edema after intracerebral hemorrhage. J. Neurol. Sci., 270, 172-183.
154. Wagner, S.L., Geddes, J.W., Cotman, C.W., Lau, A.L., Gurwitz, D., Isackson, P.J., and Cunningham, D.D. (1989) Protease nexin-1, an antithrombin with neurite outgrowth activity, is reduced in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A., 86, 8284-8288.
155. Rosenblatt, D.E., Geula, C., and Mesulam, M.M. (1989) Protease nexin I immunostaining in Alzheimer's disease. Ann. Neurol., 26, 628-634.
156. Vaughan, P.J., Su, J., Cotman, C.W., and Cunningham, D.D. (1994) Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Brain Res., 668, 160-170.
157. Choi, B.H., Kim, R.C., Vaughan, P.J., Lau, A., Van Nostrand, W.E., Cotman, C.W., and Cunningham, D.D. (1995) Decreases in protease nexins in Alzheimer's disease brain. Neurobiol. Aging, 16, 557-562.
158. Boulaftali, Y., Adam, F., Venisse, L., Ollivier, V., Richard, B., Taieb, S., Monard, D., Favier, R., Alessi, M.C., Bryckaert, M., Arocas, V., Jandrot-Perrus, M., and Bouton, M.C. (2009) Anticoagulant and antithrombotic properties of platelet protease nexin-1. Blood., 115, 97-106.
159. Bouton, M.C., Venisse, L., Richard, B., Pouzet, C., Arocas, V., and Jandrot-Perrus, M. (2007) Protease nexin-1 interacts with thrombomodulin and modulates its anticoagulant effect. Circ. Res., 100, 1174-1181.
160. Boulaftali, Y., Ho-Tin-Noe, B., Pena, A., Loyau, S., Venisse, L., Francois, D., Richard, B., Arocas, V., Collet, J.P., Jandrot-Perrus, M., and Bouton, M.C. (2011) Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis. Circulation, 123, 1326-1334.
161. Gao, S., Krogdahl, A., Sorensen, J.A., Kousted, T.M., Dabelsteen, E., and Andreasen, P.A. (2008) Overexpression of protease nexin-1 mRNA and protein in oral squamous cell carcinomas. Oral oncol., 44, 309-313.
162. Buchholz, M., Biebl, A., Neesse, A., Wagner, M., Iwamura, T., Leder, G., Adler, G., and Gress, T.M. (2003) SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo
163. Candia, B.J., Hines, W.C., Heaphy, C.M., Griffith, J.K., and Orlando, R.A. (2006) Protease nexin-1 expression is altered in human breast cancer. Cancer Cell Int., 6, 16.
164. Selzer-Plon, J., Bornholdt, J., Friis, S., Bisgaard, H.C., Lothe, I.M., Tveit, K.M., Kure, E.H., Vogel, U., and Vogel, L.K. (2009) Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer, 9, 201.
165. Thelin-Jarnum, S., Lassen, C., Panagopoulos, I., Mandahl, N., and Aman, P. (1999) Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas. Int. J. Cancer, 83, 30-33.
166. Martin, K.J., Patrick, D.R., Bissell, M.J., and Fournier, M.V. (2008) Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS ONE, 3, e2994.
167. Bianchini, G., Qi, Y., Alvarez, R.H., Iwamoto, T., Coutant, C., Ibrahim, N.K., Valero, V., Cristofanilli, M., Green, M.C., Radvanyi, L., Hatzis, C., Hortobagyi, G.N., Andre, F., Gianni, L., Symmans, W.F., and Pusztai, L. (2010) Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers. J. Clin. Oncol., 28, 4316-4323.
168. Gao, S., Nielsen, B.S., Krogdahl, A., Sorensen, J.A., Tagesen, J., Dabelsteen, S., Dabelsteen, E., and Andreasen, P.A. (2010) Epigenetic alterations of the SERPINE1 gene in oral squamous cell carcinomas and normal oral mucosa. Genes Chromosomes Cancer, 49, 526-538.
169. Yang, S., Dong, Q., Yao, M., Shi, M., Ye, J., Zhao, L., Su, J., Gu, W., Xie, W., Wang, K., Du, Y., Li, Y., and Huang, Y. (2009) Establishment of an experimental human lung adenocarcinoma cell line SPC-A-1BM with high bone metastases potency by (99m)Tc-MDP bone scintigraphy. Nucl. Med. Biol., 36, 313-321.
170. Nagahara, A., Nakayama, M., Oka, D., Tsuchiya, M., Kawashima, A., Mukai, M., Nakai, Y., Takayama, H., Nishimura, K., Jo, Y., Nagai, A., Okuyama, A., and Nonomura, N. (2010) SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochem. Biophys. Res. Commun., 391, 1641-1646.
171. Guan, H., Smirnov, D.A., and Ricciardi, R.P. (2003) Identification of genes associated with adenovirus 12 tumorigenesis by microarray. Virology, 309, 114-124.
172. Liang, X., Huuskonen, J., Hajivandi, M., Manzanedo, R., Predki, P., Amshey, J.R., and Pope, R.M. (2009) Identification and quantification of proteins differentially secreted by a pair of normal and malignant breast-cancer cell lines. Proteomics, 9, 182-193.
173. Neesse, A., Wagner, M., Ellenrieder, V., Bachem, M., Gress, T.M., and Buchholz, M. (2007) Pancreatic stellate cells potentiate proinvasive effects of SERPINE2 expression in pancreatic cancer xenograft tumors. Pancreatology, 7, 380-385.
174. Duner, S., Lopatko Lindman, J., Ansari, D., Gundewar, C., and Andersson, R. (2011) Pancreatic cancer: the role of pancreatic stellate cells in tumor progression. Pancreatology, 10, 673-681.
175. Xu, D., Suenaga, N., Edelmann, M.J., Fridman, R., Muschel, R.J., and Kessler, B.M. (2008) Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol. Cell Proteomics, 7, 2215-2228.